Welcome to the RAPAEL Home blog. We are excited to use this space to share company news, product updates, and clinical information with you.
For first-time visitors, we are NEOFECT USA, a rehabilitation device company that leverages technology to create innovative and engaging rehab solutions. Our US operations are based just outside of San Francisco, CA, and our main headquarters are located in South Korea.
Though a majority of our patients are those who have suffered a stroke, our products are appropriate for anyone who can benefit from repetition, as that is the key to improving range of motion, coordination, and timing.
The RAPAEL Smart Glove works on hand, wrist, and finger mobility
Our RAPAEL Smart Rehabilitation Solutions are designed for individuals that have experienced strokes, those who have suffered traumatic brain injuries, and patients with other injuries that have caused limitations in the shoulders, arms, hands, or fingers.
Therapy that feels like games, but works like medicine
Fun, interactive training activities encourage the participant to continue with their stroke recovery at home by performing a high number of repetitions during each session (up to 10 times the number of repetitions that someone would complete in a typical occupational therapy visit*). All of our products are built to take advantage of the brain’s neuroplasticity, or the ability of the brain to heal itself by finding new ways to perform certain tasks.
In clinical trials, patients using the RAPAEL Smart Glove saw greater improvements over those using traditional models of therapy.
Also, all training activities that come with our products have been clinically validated to help with movement recovery. And you get a 7-day free trial to see for yourself. Contact us today to get started.
* Brunner, I., Skouen, J.S., Hofstad, H., Abmuss, J., Becker, F., Pallesen, H., Thijs, L., Verheyden, G., (2016). Is upper limb virtual reality training more intensive than conventional training for patients in the subacute phase after stroke?: An analysis of treatment intensity and content. BMC Neurology, 16: 219, DOI: 10.1186/s12883-016-0740-y.